HAChE/hBACE-1-IN-4
HAChE/hBACE-1-IN-4 (compound AK-2) is a quinazoline derivative. hAChE/hBACE-1-IN-4 shows significant inhibitory activity against hAChE and hBACE-1 enzymes (hAChE, IC50=0.283 μM; hBACE-1, IC50=0.231 μM) . hAChE/hBACE-1-IN-4 has the potential to inhibit Aβ aggregation. hAChE/hBACE-1-IN-4 has non-neurotoxicity , blood-brain barrier permeability and oral activity. hAChE/hBACE-1-IN-4 can be used in Alzheimer's disease research[1].
Product Specifications
CAS Number
[229476-71-5]
UNSPSC
12352005
Target
Amyloid-β; Cholinesterase (ChE)
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/hache-hbace-1-in-4.html
Solubility
10 mM in DMSO
Smiles
COC1=C(OC)C=C2C(N(CC3)CCN3CC4=CC=CC=C4)=NC=NC2=C1
Molecular Formula
C21H24N4O2
Molecular Weight
364.44
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
AChE; BChE
Explore Other Products
Browse additional items from our catalog
CREB, phosphorylated (Ser129) (cAMP Response Element Binding Protein)
CREB, phosphorylated (Ser129) (cAMP Response Element Binding Protein)
RSPO4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
